Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome

BACKGROUND: Rifaximin is a minimally absorbed antibiotic with high luminal activity, used to treat various gastrointestinal diseases. Although rifaximin has been proposed as first line treatment for small intestinal bacterial overgrowth (SIBO), few data are available regarding its efficacy in non-IB...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Boltin, Doron, Perets, Tsachi Tsadok, Shporn, Einav, Aizic, Shoshana, Levy, Sigal, Niv, Yaron, Dickman, Ram
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201689/
https://ncbi.nlm.nih.gov/pubmed/25319626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12941-014-0049-x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы